These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

381 related items for PubMed ID: 9843792

  • 1. Heart and lung VEGF mRNA expression in rats with monocrotaline- or hypoxia-induced pulmonary hypertension.
    Partovian C, Adnot S, Eddahibi S, Teiger E, Levame M, Dreyfus P, Raffestin B, Frelin C.
    Am J Physiol; 1998 Dec; 275(6):H1948-56. PubMed ID: 9843792
    [Abstract] [Full Text] [Related]

  • 2. Allogenic stem cell therapy improves right ventricular function by improving lung pathology in rats with pulmonary hypertension.
    Umar S, de Visser YP, Steendijk P, Schutte CI, Laghmani el H, Wagenaar GT, Bax WH, Mantikou E, Pijnappels DA, Atsma DE, Schalij MJ, van der Wall EE, van der Laarse A.
    Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1606-16. PubMed ID: 19783775
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Vascular endothelial growth factor expression in heart of rats exposed to hypobaric hypoxia: differential response between mRNA and protein.
    Birot OJ, Peinnequin A, Simler N, van Cuyck-Gandré H, Hamel R, Bigard XA.
    J Cell Physiol; 2004 Jul; 200(1):107-15. PubMed ID: 15137063
    [Abstract] [Full Text] [Related]

  • 6. Pathophysiology of infantile pulmonary arterial hypertension induced by monocrotaline.
    Dias-Neto M, Luísa-Neves A, Pinho S, Gonçalves N, Mendes M, Eloy C, Lopes JM, Gonçalves D, Ferreira-Pinto M, Leite-Moreira AF, Henriques-Coelho T.
    Pediatr Cardiol; 2015 Jun; 36(5):1000-13. PubMed ID: 25608696
    [Abstract] [Full Text] [Related]

  • 7. Prolonged inhaled NO attenuates hypoxic, but not monocrotaline-induced, pulmonary vascular remodeling in rats.
    Horstman DJ, Frank DU, Rich GF.
    Anesth Analg; 1998 Jan; 86(1):74-81. PubMed ID: 9428855
    [Abstract] [Full Text] [Related]

  • 8. Right Ventricle Remodeling Metabolic Signature in Experimental Pulmonary Hypertension Models of Chronic Hypoxia and Monocrotaline Exposure.
    Hautbergue T, Antigny F, Boët A, Haddad F, Masson B, Lambert M, Delaporte A, Menager JB, Savale L, Pavec JL, Fadel E, Humbert M, Junot C, Fenaille F, Colsch B, Mercier O.
    Cells; 2021 Jun 21; 10(6):. PubMed ID: 34205639
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Hypoxia-inducible factor 1alpha regulates vascular endothelial growth factor's roles on pulmonary arteries of rats with hypoxia-induced pulmonary hypertension].
    Li QF, Dai AG.
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Mar 21; 27(3):174-8. PubMed ID: 15130328
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Fluoxetine protects against monocrotaline-induced pulmonary arterial remodeling by inhibition of hypoxia-inducible factor-1α and vascular endothelial growth factor.
    Han DD, Wang Y, Zhang XH, Liu JR, Wang HL.
    Can J Physiol Pharmacol; 2012 Apr 21; 90(4):445-54. PubMed ID: 22448962
    [Abstract] [Full Text] [Related]

  • 13. [Changes of the gene expression of vascular endothelial growth factor in the lung of rats with chronic hypoxic pulmonary hypertension].
    Chen W, Cheng D, Wu Q.
    Hua Xi Yi Ke Da Xue Xue Bao; 1998 Sep 21; 29(3):233-6. PubMed ID: 10684080
    [Abstract] [Full Text] [Related]

  • 14. Cardiac and lung VEGF mRNA expression in chronically hypoxic and monocrotaline-treated rats.
    Partovian C, Ladoux A, Eddahibi S, Teiger E, Raffestin B, Frelin C, Adnot S.
    Chest; 1998 Jul 21; 114(1 Suppl):45S-46S. PubMed ID: 9676624
    [No Abstract] [Full Text] [Related]

  • 15. Model difference in the effect of cilostazol on the development of experimental pulmonary hypertension in rats.
    Ito T, Zhang E, Omori A, Kabwe J, Kawai M, Maruyama J, Okada A, Yokochi A, Sawada H, Mitani Y, Maruyama K.
    BMC Pulm Med; 2021 Nov 20; 21(1):377. PubMed ID: 34801000
    [Abstract] [Full Text] [Related]

  • 16. Chronic hypoxia- and monocrotaline-induced elevation of hypoxia-inducible factor-1 alpha levels and pulmonary hypertension.
    Lai YL, Law TC.
    J Biomed Sci; 2004 Nov 20; 11(3):315-21. PubMed ID: 15067214
    [Abstract] [Full Text] [Related]

  • 17. Myocardial dysfunction and neurohumoral activation without remodeling in left ventricle of monocrotaline-induced pulmonary hypertensive rats.
    Lourenço AP, Roncon-Albuquerque R, Brás-Silva C, Faria B, Wieland J, Henriques-Coelho T, Correia-Pinto J, Leite-Moreira AF.
    Am J Physiol Heart Circ Physiol; 2006 Oct 20; 291(4):H1587-94. PubMed ID: 16679394
    [Abstract] [Full Text] [Related]

  • 18. Upregulation of GLUT-4 in right ventricle of rats with monocrotaline-induced pulmonary hypertension.
    Broderick TL, King TM.
    Med Sci Monit; 2008 Dec 20; 14(12):BR261-4. PubMed ID: 19043358
    [Abstract] [Full Text] [Related]

  • 19. Time course and mechanisms of left ventricular systolic and diastolic dysfunction in monocrotaline-induced pulmonary hypertension.
    Correia-Pinto J, Henriques-Coelho T, Roncon-Albuquerque R, Lourenço AP, Melo-Rocha G, Vasques-Nóvoa F, Gillebert TC, Leite-Moreira AF.
    Basic Res Cardiol; 2009 Sep 20; 104(5):535-45. PubMed ID: 19288153
    [Abstract] [Full Text] [Related]

  • 20. Expression profile of matricellular proteins in hypertrophied right ventricle of monocrotaline-induced pulmonary hypertensive rats.
    Imoto K, Okada M, Yamawaki H.
    J Vet Med Sci; 2017 Jun 29; 79(6):1096-1102. PubMed ID: 28496027
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.